Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$37,232,503
-$10,500,407 QoQ
Shares Held
83,380
-20.8% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 36.31566322859199.ToString("F0")%
Shared 0.ToString("F0")%
None 63.68433677140801.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $92,341,956 across 47 Biotechnology names. VRTX ranks #1 (40.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
83,380 | $37,232,503 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,794 | $22,247,395 | |
| 3 | MRNA |
Moderna, Inc.
|
163,422 | $8,301,837 | |
| 4 | BNTX |
BioNTech SE
|
93,107 | $8,275,350 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,476 | $1,811,842 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
17,872 | $1,327,174 | |
| 7 | MCRB |
Seres Therapeutics, Inc.
|
138,468 | $1,228,211 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
135,605 | $1,148,574 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,232,503 | 83,380 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $47,732,910 | 105,287 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $43,331,831 | 110,642 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $31,964,468 | 71,798 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $36,267,443 | 74,806 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $76,089,760 | 188,949 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $52,691,700 | 113,296 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $74,446,796 | 158,830 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $45,303,922 | 108,380 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $24,996,878 | 61,434 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $23,519,045 | 67,634 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $23,928,822 | 67,997 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $18,151,180 | 57,610 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $18,106,215 | 62,699 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,119,340 | 59,126 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $20,510,928 | 72,788 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $23,667,628 | 90,691 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,626,661 | 116,697 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,729,782 | 97,744 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $15,813,032 | 78,426 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $14,320,268 | 66,640 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $13,723,790 | 58,068 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||